![](/img/cover-not-exists.png)
A phase III randomized controlled clinical trial of carboplatin and paclitaxel alone or in combination with bevacizumab followed by bevacizumab and secondary cytoreductive surgery in platinum-sensitive, recurrent ovarian, peritoneal primary and fallopian tube cancer (Gynecologic Oncology Group 0213)
Coleman, R.L., Brady, M.F., Herzog, T.J., Sabbatini, P., Armstrong, D.K., Walker, J.L., Kim, B.G., Fujiwara, K., Tewari, K.S., O'Malley, D.M.Volume:
137
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2015.01.005
Date:
April, 2015
File:
PDF, 275 KB
english, 2015